Shares of XenoPort, Inc. XNPT are higher on the session by 1.62%, trading at $7.55.
Overall put volume is now running at 2.35x the daily average, with 63% of all puts traded being purchases on the offer. 2,555 contracts have traded on the session so far.
XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates, which utilizes the body's natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in